Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 20838224)

1.

Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.

Hong SY, Jonas A, Dumeni E, Badi A, Pereko D, Blom A, Muthiani VS, Shiningavamwe AN, Mukamba J, Andemichael G, Barbara R, Bennett DE, Jordan MR.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.

2.

HIV drug resistance early warning indicators in Namibia for public health action.

Jonas A, Gweshe J, Siboleka M, Deklerk M, Gawanab M, Badi A, Sumbi V, Pereko D, Blom A, Mwinga S, Jordan MR, Jerger L, Lau K, Hong SY.

PLoS One. 2013 Jun 7;8(6):e65653. doi: 10.1371/journal.pone.0065653. Print 2013.

3.

HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.

Jonas A, Sumbi V, Mwinga S, DeKlerk M, Tjituka F, Penney S, Jordan MR, Desta T, Tang AM, Hong SY.

PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.

4.

Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

Dzangare J, Gonese E, Mugurungi O, Shamu T, Apollo T, Bennett DE, Kelley KF, Jordan MR, Chakanyuka C, Cham F, Banda RM.

Clin Infect Dis. 2012 May;54 Suppl 4:S313-6. doi: 10.1093/cid/cir1014.

5.

Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.

Fokam J, Billong SC, Bissek AC, Kembou E, Milenge P, Abessouguie I, Nkwescheu AS, Tsomo Z, Aghokeng AF, Ngute GD, Ndumbe PM, Colizzi V, Elat JB.

BMC Public Health. 2013 Apr 8;13:308. doi: 10.1186/1471-2458-13-308.

6.

HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.

Bennett DE, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF.

Clin Infect Dis. 2012 May;54 Suppl 4:S280-9. doi: 10.1093/cid/cis207.

7.

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.

Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D.

Antivir Ther. 2008;13 Suppl 2:15-23.

PMID:
18575188
8.

Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.

Juma JM, Tiberio JK, Abuya MI, Kilama BK, Somi GR, Sambu V, Banda R, Jullu BS, Ramadhani AA.

BMC Infect Dis. 2014 Apr 11;14:196. doi: 10.1186/1471-2334-14-196.

9.

Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.

Sigaloff KC, Hamers RL, Menke J, Labib M, Siwale M, Ive P, Botes ME, Kityo C, Mandaliya K, Wellington M, Osibogun A, Geskus RB, Stevens WS, van Vugt M, Rinke de Wit TF; PharmAccess African Studies to Evaluate Resistance.

Clin Infect Dis. 2012 May;54 Suppl 4:S294-9. doi: 10.1093/cid/cir1015.

10.

Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.

Do TN, Nguyen TM, Do MH, Masaya K, Dang TB, Pham TL, Yoshikawa K, Cao TT, Nguyen TT, Bui DD, Nguyen VK, Nguyen TL, Fujita M.

Clin Infect Dis. 2012 May;54 Suppl 4:S306-12. doi: 10.1093/cid/cir1045.

11.

Early warning indicators for HIV drug resistance in Cameroon during the year 2010.

Billong SC, Fokam J, Nkwescheu AS, Kembou E, Milenge P, Tsomo Z, Dion GN, Aghokeng AF, Mpoudi EN, Ndumbe PM, Colizzi V, Elat Nfetam JB.

PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.

12.

Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.

Hong SY, Jonas A, DeKlerk M, Shiningavamwe A, Desta T, Badi A, Morris L, Hunt GM, Ledwaba J, Sheehan HB, Lau K, Trotter A, Tang AM, Wanke C, Jordan MR.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):463-71. doi: 10.1097/QAI.0000000000000509.

PMID:
25564107
13.

Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.

Dube NM, Tint KS, Summers RS.

Clin Infect Dis. 2014 Jun;58(11):1607-14. doi: 10.1093/cid/ciu109. Epub 2014 Feb 27.

14.

Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.

Ma Y, Zhang F, Li H, Wu H, Zhang J, Ding Y, Zhao D, Fang H, Zhou S, Liu Z, Zhang L, Osborne C, Seguy N, Zhao Y.

Clin Infect Dis. 2012 May;54 Suppl 4:S300-2. doi: 10.1093/cid/cir1018.

15.

Early warning indicators for HIV drug resistance in Malawi.

Hedt BL, Wadonda-Kabondo N, Makombe S, Harries AD, Schouten EJ, Limbambala E, Hochgesang M, Aberle-Grosse J, Kamoto K.

Antivir Ther. 2008;13 Suppl 2:69-75.

PMID:
18575193
16.

Implementing early-warning indicators of HIV drug resistance in the Caribbean.

Jack N, Ravasi G, Schrooten W, Sutherland D, Ghidinelli M, Del Riego A.

Clin Infect Dis. 2012 May;54 Suppl 4:S290-3. doi: 10.1093/cid/cir1044.

17.

Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.

Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C.

Clin Infect Dis. 2012 May;54 Suppl 4:S362-8. doi: 10.1093/cid/cir987.

18.

Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.

Daoni E, Kitur U, Parunga A, Ndenzako F, Lloyd A, Yu D.

Clin Infect Dis. 2012 May;54 Suppl 4:S303-5. doi: 10.1093/cid/cir994.

19.

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

Bennett DE, Bertagnolio S, Sutherland D, Gilks CF.

Antivir Ther. 2008;13 Suppl 2:1-13.

PMID:
18578063
20.

Determinants of HIV drug resistance and public health implications in low- and middle-income countries.

Bertagnolio S, De Luca A, Vitoria M, Essajee S, Penazzato M, Hong SY, McClure C, Duncombe C, Jordan MR.

Antivir Ther. 2012;17(6):941-53. doi: 10.3851/IMP2320. Epub 2012 Aug 16. Review.

PMID:
22898622
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk